Related Experiment Video

Updated: May 23, 2026

Making MR Imaging Child's Play - Pediatric Neuroimaging Protocol, Guidelines and Procedure
15:18

Making MR Imaging Child's Play - Pediatric Neuroimaging Protocol, Guidelines and Procedure

Published on: July 30, 2009

Pediatric migraine teaching for families

Lindsay Craddock1, Lynne D Ray

  • 1Stollery Children's Hospital, Alberta, Canada. lindsay.craddock@albertahealthservices.ca

Journal for Specialists in Pediatric Nursing : JSPN
|April 3, 2012
PubMed

Insights

Pediatric migraine management requires family education on biobehavioral strategies, lifestyle changes, and medication. This approach aims to reduce pain, prevent chronic daily headaches, and minimize overall attacks.

Area of Science:

  • Pediatric Neurology
  • Clinical Management
  • Evidence-Based Practice

Background:

  • Pediatric migraine significantly impacts quality of life.
  • Effective management strategies are crucial for reducing acute pain and preventing chronicity.
  • Family education is a cornerstone of successful pediatric migraine treatment.

Purpose of the Study:

  • To summarize current evidence on pediatric migraine management.
  • To provide a foundation for family teaching and education.
  • To outline key components for effective child and family education.

Main Methods:

  • Literature review of current evidence on pediatric migraine management.
  • Synthesis of information on biobehavioral strategies, lifestyle modifications, and pharmacologic treatment.
  • Development of recommendations for goal setting and trigger identification.

Main Results:

  • Pediatric migraine management is most effective with a multimodal approach.
  • Tailored biobehavioral strategies and lifestyle modifications are essential.
  • Optimal scheduling of rescue and preventative pharmacologic treatments is key.

Conclusions:

  • Comprehensive education empowers families to manage pediatric migraine effectively.
  • A combination of tailored biobehavioral, lifestyle, and pharmacologic interventions is recommended.
  • Resources such as goal setting, trigger identification, and management principles support effective treatment.
Abstract

More Related Videos

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache10:39

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache

Published on: June 2, 2014

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...